Andrew Mullen, Charco Neurotech - CUE1+: A Device for Parkinson's | LSI USA '25

Charco Neurotech is dedicated to improving the quality of life for individuals with Parkinson's disease through its cutting-edge wearable technology, the CUE1 device, which aims to alleviate motor symptoms and enhance patient mobility.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Andrew Mullen
Andrew Mullen
Chief Operating Officer, Charco Neurotech